WebCisplatin plus radiation therapy Advanced-stage squamous cell cancer of the head and neck remains a difficult therapeutic dilemma despite aggressive use of surgery and … WebThe TPF triplet regimen (docetaxel, cisplatin, and 5‐FU) has a trend of further improving treatment efficacy compared with the traditional doublet regimen. 35 , 36 In a phase II study, concurrent chemoradiotherapy with TPF achieved a clinical CR rate of 52.4%, much higher than the previously reported CR rate of 20%. 9 However, the high ...
Chemoradiation therapy for anal cancer: radiation plus ... - PubMed
WebApr 14, 2024 · Instead, cross-resistance to cisplatin (RI = 2.9) and 5-FU (RI = 23.6) was observed in TGBC1 GemR . 2.2. Gemcitabine-Resistant Cells Exhibit an EMT Signature and Dysregulation of Metabolic Pathways. The gene expression profiling revealed a very clear distinction between parental and gemcitabine-resistant cells . The extensive ... WebMar 16, 2024 · We randomly assigned eligible patients between the ages of 18 and 70 years who had stage III or stage IV disease and no distant metastases to receive either TPF (docetaxel and cisplatin, day 1;... readyprint go avis
Multidisciplinary management in the treatment of intrahepatic ...
WebFeb 1, 2024 · View a regimen chart with detailed drug information for treating anal cancer, including 5-fluorouracil + mitomycin + radiotherapy or 5FU + cisplatin. WebJun 5, 2024 · Background: Chemoradiotherapy (CRT) including three cycles of cisplatin is considered the standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, around one-third of the patients cannot complete cisplatin because of toxicity. Carboplatin plus 5-fluorouracil (carbo-5FU) is another … WebIn 18 patients receiving 5-FU plus cisplatin with radiation doses of 54-55 Gy, actuarial local control was 85% at 2 years. Fifteen patients failed chemoXRT, 13 of whom had abdominoperineal resection for salvage; the overall local control rate was 93% (54/58). The actuarial survival at 5 years was 81% for the 5-FU chemoXRT group and 94% at 2 ... readyprep pvp